Related Experiment Videos
[Expression and function of proteins associated with multidrug resistance]
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|March 1, 1989
Summary
Researchers identified key proteins in multidrug-resistant tumor cells, including P-glycoprotein that pumps out chemotherapy drugs. Monoclonal antibodies to these proteins show promise for diagnosing clinical drug resistance.
Area of Science:
- Molecular Biology
- Cancer Research
- Biochemistry
Background:
- Multidrug resistance (MDR) in tumor cells poses a significant challenge in cancer chemotherapy.
- Identifying specific proteins associated with MDR is crucial for understanding resistance mechanisms and developing diagnostic tools.
Purpose of the Study:
- To identify and characterize proteins specifically expressed in multidrug-resistant tumor cells.
- To investigate the functions of these identified proteins in drug resistance.
- To explore the potential diagnostic utility of these proteins in clinical settings.
Main Methods:
- Proteomic analysis of multidrug-resistant tumor cells.
- Characterization of protein function, including ATPase activity and calcium binding.
- Development and application of monoclonal antibodies for protein detection.
Main Results:
- Identified P-glycoprotein (170-180 kDa), an ATPase functioning as a drug efflux pump in resistant cells.
- Identified sorcin (22 kDa), a calcium-binding protein with an undetermined function.
- Discovered an 85 kDa membrane protein specifically expressed and induced by adriamycin in resistant cells, indicating a unique resistance mechanism.
Conclusions:
- Specific proteins are uniquely expressed in multidrug-resistant cells, offering insights into resistance mechanisms.
- P-glycoprotein and the adriamycin-induced protein play key roles in mediating drug resistance.
- Monoclonal antibodies against these proteins represent potential tools for diagnosing clinical drug resistance.